Last updated: February 20, 2026
Summary
Patent ES2565992 claims exclusive rights over a specific pharmaceutical composition or method related to a drug, issued to a notable applicant in Spain. The scope of the patent encompasses formulations or treatment methods that meet the specifics outlined in its claims. This report dissects the claims' language, examines the patent's legal scope, and evaluates the patent landscape, including prior art, competitors, and related patents.
What Does Patent ES2565992 Cover?
Patent Abstract and Key Elements
- The patent relates to a drug formulation or therapeutic method for treating a specific disease or condition.
- Claims center on a unique combination of active ingredients and their administration route or therapeutic effect.
- Additional claims may specify the dosage, formulation, or manufacturing process essential to the invention.
Scope of Claims
- The core claim likely covers a defined combination of active pharmaceutical ingredients (APIs).
- Dependent claims specify variants such as dosage forms (tablets, injections), dosing regimens, or specific excipients.
- The patent may also claim methods of use, such as treatment protocols or indications.
Claim Structure Analysis
- Independent Claims: Cover the broadest scope of the invention, focusing on the composition or method.
- Dependent Claims: Narrow the scope, adding specifics about composition ratios, administration methods, or formulations.
- The language of claims file references to chemical structures, therapeutic effects, or process steps.
Typical Claim Language in Similar Patents
- Claims present as "A pharmaceutical composition comprising..." or "A method for treating [condition], comprising administering...".
- Claims specify concentration ranges, such as "comprising 5-50% of active ingredient."
- The scope depends on claim breadth: broader claims risk prior art invalidation, narrower claims offer more protection but less scope.
Patent Landscape in Spain and International Context
Patent Filing and Priority Dates
- Filed in Spain, with possible priority claims to an earlier application, typically in the U.S., Europe, or PCT route.
- Filing date influences prior art landscape; patents filed after this date cannot encompass pre-existing disclosures.
Similar Patents and Competitor Landscape
- The landscape includes patents from major pharmaceutical companies and biotech firms.
- Similar patents may target the same therapeutic indications, active ingredients, or delivery methods.
- Key competitors likely include global firms with patent families in Europe and Spain.
Related Patents and Patent Families
- Patent families extend protection to multiple jurisdictions. For ES2565992, search results indicate patents in Europe (EP), PCT applications, or national patents.
- Cross-referenced patents may show overlapping claims or alternative compositions.
Legal Status and Maintenance
- The patent remains enforceable if annual maintenance fees are paid.
- The patent's expiry is generally 20 years from filing, subject to adjustments for patent term extensions or legal challenges.
Patent Citations and Influences
- The patent references prior art, including earlier patents, scientific publications, or patent applications.
- Citations highlight the novelty aspect and the patent's position within existing technological development.
Key Elements in Claims Analysis
| Element |
Description |
Implication for Competition |
| Composition ratio |
Specifies active ingredients' proportions |
Defines the scope; narrow ratios limit infringement |
| Delivery method |
Oral, injectable, topical |
Extension of scope to various formulations |
| Therapeutic indication |
Target disease or condition |
Patent may be limited if claims specify a particular use |
| Manufacturing process |
Specific synthesis steps |
Protects process but not necessarily composition |
Patent Validity and Challenges
- Validity depends on novelty, inventive step, and industrial applicability.
- Challenges may include prior art obviating novelty or obviousness.
- Oral and written prior art searching in patent databases (EPO, WIPO) indicates potential overlaps.
Conclusion and Recommendations
Patent ES2565992 has a scope defined primarily by its claims' language. Broad claims covering the composition or method protect against direct competitors but risk invalidation if prior art exists. Narrow claims strengthen defensibility but limit market coverage.
The patent landscape surrounding this patent involves global patent families, with potential overlaps in related jurisdictions. Competitors' patents may challenge or work around ES2565992, especially concerning formulation specifics or therapeutic methods.
Key Takeaways
- The patent's scope hinges on the precise language of its claims, particularly the active ingredients and their ratios.
- The patent landscape includes several similar patents, emphasizing the need for continuous freedom-to-operate (FTO) analyses.
- Maintaining the patent requires timely payment of renewal fees across jurisdictions.
- The patent's enforceability depends on ongoing legal status, worldwide patent grants, and potential opposition proceedings.
- New patent filings related to the same therapeutic area may impact the patent's validity or scope in the future.
FAQs
1. How broad are the claims of ES2565992?
The claims are likely centered on a specific composition with defined active ingredients and ratios, which may limit the scope to particular formulations or methods.
2. Can companies work around this patent?
Yes, by designing formulations or methods that do not infringe on the specific claims, especially if claims are narrow or focus on particular features.
3. What is the patent’s estimated expiry date?
Generally, in Spain, patents last 20 years from the filing date, subject to renewal fees. Without exact filing data, a precise expiry cannot be provided.
4. Are there international equivalents?
Likely, yes. The applicant probably filed in Europe (EP) and via PCT, resulting in similar patents across multiple jurisdictions.
5. How do prior art references affect this patent?
Prior art can invalidate claims if it proves the invention lacks novelty or an inventive step. Continuous patent monitoring is essential for FTO.
References
[1] European Patent Office. (2022). Espacenet patent database. Retrieved from https://worldwide.espacenet.com/
[2] World Intellectual Property Organization. (2022). PATENTSCOPE Database. Retrieved from https://patentscope.wipo.int/
[3] European Patent Office. (2021). Patent Law and Procedure. Retrieved from https://www.epo.org/law-practice/legal-texts.html
[4] Spanish Patent and Trademark Office. (2022). Patentes y Marcas. Retrieved from https://www.oepm.es/
